Greg Rossi

Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery.

Massimo Scerrati, R. Roselli, Maurizio Iacoangeli et al. · Journal of Neurology Neurosurgery & Psychiatry · 1996 · 135 citations · Full text

Medicine, Oncology, Surgery +16

A Randomized Comparison of Every-2-Week Darbepoetin Alfa and Weekly Epoetin Alfa for the Treatment of Chemotherapy-Induced Anemia in Patients With Breast, Lung, or Gynecologic Cancer

Lee S. Schwartzberg, Lorrin Yee, Frank M. Senecal et al. · The Oncologist · 2004 · 105 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +7

Randomized, Double-Blind, Active-Controlled Trial of Every-3-Week Darbepoetin Alfa for the Treatment of Chemotherapy-Induced Anemia

Jean-Luc Canon, Johan Vansteenkiste, G. Bodoky et al. · JNCI Journal of the National Cancer Institute · 2006 · 104 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Effects of chemotherapy on endogenous erythropoietin levels and the pharmacokinetics and erythropoietic response of darbepoetin alfa: A randomised clinical trial of synchronous versus asynchronous dosing of darbepoetin alfa

John A. Glaspy, David H. Henry, Ravi Patel et al. · European Journal of Cancer · 2005 · 90 citations

Pharmacy, Pharmacokinetics, Pharmacology +9

Randomized Comparison of Every-2-Week Darbepoetin Alfa and Weekly Epoetin Alfa for the Treatment of Chemotherapy-Induced Anemia: The 20030125 Study Group Trial

John A. Glaspy, Saroj Vadhan‐Raj, Ravi Patel et al. · Journal of Clinical Oncology · 2006 · 78 citations

Medicine, Hematology, Pharmacology +16